ENDRA Life Sciences (NDRA) Gross Profit (2016 - 2018)

ENDRA Life Sciences has disclosed Gross Profit across 3 years of filings, most recently posting $6174.0 for Q1 2018.

• In Q1 2018, Gross Profit changed N/A year-over-year to $6174.0; the TTM figure through Dec 2018 stood at $6174.0 (down 96.55% YoY), while the FY2018 annual figure was $6174.0, down 96.55% from the prior year.
• Gross Profit climbed to $6174.0 in Q1 2018, from $3765.0 in the prior quarter.
• Over the last five years, Gross Profit for NDRA reached as high as $279704.0 in Q4 2016 and fell as low as $3765.0 in Q4 2017.
• The 3-year median for Gross Profit is $6345.0 (2017), against an average of $92943.6.
• The widest YoY moves for Gross Profit: up 98.65% in 2017, down 98.65% in 2017.
• A 3-year view of Gross Profit shows it stood at $279704.0 in 2016, then plunged by 98.65% to $3765.0 in 2017, then jumped by 63.98% to $6174.0 in 2018.
• According to Business Quant data, Gross Profit over the past three periods registered $6174.0, $3765.0, and $168730.0 for Q1 2018, Q4 2017, and Q3 2017 respectively.